Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
GAVE
MCID: GST020
MIFTS: 40

Gastric Antral Vascular Ectasia (GAVE)

Categories: Blood diseases, Cardiovascular diseases, Gastrointestinal diseases, Rare diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Gastric Antral Vascular Ectasia

About this section

MalaCards integrated aliases for Gastric Antral Vascular Ectasia:

Name: Gastric Antral Vascular Ectasia 12 20 44 15 17
Watermelon Stomach 12 74 20
Gave 20

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Cardiovascular diseases Gastrointestinal diseases Blood diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:2493
MeSH 44 D020252
NCIt 50 C84724
SNOMED-CT 67 412795008
UMLS 71 C0267211
Sources

Summaries for Gastric Antral Vascular Ectasia

About this section
GARD : 20 Watermelon stomach is a condition in which the lining of the stomach bleeds, causing it to look like the characteristic stripes of a watermelon when viewed by endoscopy. Although it can develop in men and women of all ages, watermelon stomach is most commonly observed in older women (over age 70 years). Signs and symptoms of watermelon stomach include blood in the stool, hematemesis (vomiting blood) and anemia. The exact cause of watermelon stomach is unknown; however, it is often diagnosed in people with other chronic (long-term) conditions such as cirrhosis (scarring of the liver and poor liver function), autoimmune disease, systemic sclerosis, and CREST syndrome. Treatment consists of surgery and/or medications to stop or control the bleeding.

MalaCards based summary : Gastric Antral Vascular Ectasia, also known as watermelon stomach, is related to active peptic ulcer disease and gastritis. An important gene associated with Gastric Antral Vascular Ectasia is MIR3677 (MicroRNA 3677), and among its related pathways/superpathways are Salivary secretion and Secretion of Hydrochloric Acid in Parietal Cells. The drugs Iron and Levoleucovorin have been mentioned in the context of this disorder. Affiliated tissues include liver, skin and bone, and related phenotype is digestive/alimentary.

Wikipedia : 74 Gastric antral vascular ectasia (GAVE) is an uncommon cause of chronic gastrointestinal bleeding or iron... more...

Sources

Related Diseases for Gastric Antral Vascular Ectasia

About this section

Diseases related to Gastric Antral Vascular Ectasia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 334)
# Related Disease Score Top Affiliating Genes
1 active peptic ulcer disease 31.2 SST ATP4A ATP12A
2 gastritis 30.9 SST GAST ATP4A
3 esophageal varix 30.8 SST ATP4A ATP12A
4 angiodysplasia 30.7 SST ATP4A ATP12A
5 telangiectasis 30.4 TOP1 CENPS
6 crest syndrome 30.2 TOP1 CENPS
7 gastric ulcer 30.1 SST GAST
8 pernicious anemia 30.0 SST GAST ATP4A ATP12A
9 diffuse scleroderma 30.0 TOP1 OXCT1
10 pyloric stenosis 30.0 SST GAST
11 exanthem 29.5 ATP4A ATP12A
12 limited scleroderma 29.4 TOP1 OXCT1 CENPS
13 small cell cancer of the lung 29.4 TOP1 SST GAST
14 transcobalamin ii deficiency 11.0
15 iron metabolism disease 11.0
16 deficiency anemia 11.0
17 iron deficiency anemia 10.9
18 scleroderma, familial progressive 10.9
19 liver cirrhosis 10.9
20 hyperlipidemia, familial combined, 3 10.9
21 marfan syndrome 10.9
22 pseudo-von willebrand disease 10.9
23 spherocytosis, type 1 10.9
24 oeis complex 10.9
25 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 1 10.9
26 smith-lemli-opitz syndrome 10.9
27 ichthyosis, x-linked 10.9
28 sacral defect with anterior meningocele 10.9
29 agammaglobulinemia 1, autosomal recessive 10.9
30 ehlers-danlos syndrome 10.9
31 portal hypertension 10.8
32 chronic kidney disease 10.7
33 systemic scleroderma 10.6
34 varicose veins 10.6
35 primary biliary cholangitis 10.5
36 connective tissue disease 10.5
37 end stage renal disease 10.5
38 autoimmune disease 10.4
39 atrophic gastritis 10.4
40 sjogren syndrome 10.3
41 gastrointestinal stromal tumor 10.3
42 alcoholic liver cirrhosis 10.3
43 proctitis 10.3
44 liver disease 10.3
45 kidney disease 10.3
46 radiation proctitis 10.3
47 refractory anemia 10.3
48 vagus nerve disease 10.2 ATP4A ATP12A
49 necrotizing gastritis 10.2 ATP4A ATP12A
50 scalp dermatosis 10.2 ATP4A ATP12A

Graphical network of the top 20 diseases related to Gastric Antral Vascular Ectasia:



Diseases related to Gastric Antral Vascular Ectasia
Sources

Symptoms & Phenotypes for Gastric Antral Vascular Ectasia

About this section

MGI Mouse Phenotypes related to Gastric Antral Vascular Ectasia:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.02 ANGPTL4 ATP12A ATP4A GAST SST
Sources

Drugs & Therapeutics for Gastric Antral Vascular Ectasia

About this section

Drugs for Gastric Antral Vascular Ectasia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 92)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Iron Approved Phase 4 7439-89-6 23925 29936
2
Levoleucovorin Approved, Investigational Phase 4 68538-85-2 149436
3
Zinc Approved, Investigational Phase 4 7440-66-6 32051
4
Empagliflozin Approved Phase 4 864070-44-0
5
Folic acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
6
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4 1406-16-2
7 Insulin, Globin Zinc Phase 4
8 insulin Phase 4
9 Trace Elements Phase 4
10 Vitamin B Complex Phase 4
11 Folate Phase 4
12 Vitamin B9 Phase 4
13 Nutrients Phase 4
14 Zinc Supplement Phase 4
15 Micronutrients Phase 4
16 Hypoglycemic Agents Phase 4
17 Vitamins Phase 4
18 Calciferol Phase 4
19 Sodium-Glucose Transporter 2 Inhibitors Phase 4
20
Guaifenesin Approved, Investigational, Vet_approved Phase 2, Phase 3 93-14-1 3516
21
Metformin Approved Phase 2, Phase 3 657-24-9 14219 4091
22
Methylcobalamin Approved, Investigational Phase 2, Phase 3 13422-55-4
23 Proton Pump Inhibitors Phase 2, Phase 3
24 Hemostatics Phase 2, Phase 3
25 Chlorpheniramine, phenylpropanolamine drug combination Phase 2, Phase 3
26 Coagulants Phase 2, Phase 3
27 Calcium, Dietary Phase 2, Phase 3
28 Calcium Dobesilate Phase 2, Phase 3
29 Sunflower Phase 3
30
Calcium Nutraceutical Phase 2, Phase 3 7440-70-2 271
31
Ferrous succinate Approved Phase 2 10030-90-7
32
Ketamine Approved, Vet_approved Phase 2 6740-88-1 3821
33
Memantine Approved, Investigational Phase 2 19982-08-2 4054
34
Dextromethorphan Approved Phase 2 125-71-3 5360696 5362449
35
Dopamine Approved Phase 2 51-61-6, 62-31-7 681
36
Lactulose Approved Phase 2 4618-18-2 11333
37
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2 1177-87-3
38
Lenalidomide Approved Phase 2 191732-72-6 216326
39
Dexamethasone Approved, Investigational, Vet_approved Phase 2 50-02-2 5743
40
Bortezomib Approved, Investigational Phase 2 179324-69-7 387447 93860
41
Aspartic acid Approved, Nutraceutical Phase 2 56-84-8 5960
42 Immunosuppressive Agents Phase 2
43 Hematinics Phase 2
44 Anti-Infective Agents Phase 2
45 Anti-Bacterial Agents Phase 2
46 Dopamine Agents Phase 2
47 Respiratory System Agents Phase 2
48 Antiparkinson Agents Phase 2
49 Antitussive Agents Phase 2
50 Neurotransmitter Agents Phase 2

Interventional clinical trials:

(show top 50) (show all 64)
# Name Status NCT ID Phase Drugs
1 Effect of SGLT2 Inhibitor on Blood Glucose Profile in Type 2 Diabetic Patients Using Basal Unknown status NCT03631134 Phase 4 SGLT2 inhibitor
2 Delivery of Iron and Zinc Supplements: Evaluation of Interaction Effect on Biochemical and Clinical Outcomes Completed NCT00470158 Phase 4
3 Effects of Vitamin D Supplements on Pregnancy Outcomes in Embriyo Transfer Cycles Completed NCT03890458 Phase 4 DEVIT-3
4 Anti-anginal and Antiischemic Effects of Empagliflozin in Diabetic Patients With Refractory Angina:A Phase III, Multicentre, Randomised, Parallel Group, Double Blind Cardiovascular Safety Study of BI 10773 (10 mg Administered Orally Once Daily) Compared to Placebo in Type 2 Diabetes Mellitus Patients With Refractory Angina(EMPT-ANGIN TRIAL) Completed NCT04143321 Phase 4 Empagliflozin 25 MG
5 Morquio's Syndrome: a Case Study Terminated NCT00609440 Phase 4
6 Prospective Randomized Study of Cryotherapy Versus Argon Plasma Coagulation Therapy for Treatment Of Watermelon Stomach Completed NCT00587405 Phase 2, Phase 3
7 Endoscopic Band Ligation vs Argon Plasma Coagulation for the Treatment of Gastric Antral Vascular Ectasia: a Randomized Clinical Trial Completed NCT01601639 Phase 3
8 Liaoning University of Traditional Chinese Medicine Completed NCT03167918 Phase 2, Phase 3 Calcium Dobesilate;Xuefuzhuyu Decoction;Xuefuzhuyu Decoction & Calcium dobesilate;metformin;Mecobalamin Tablets
9 Increasing Walking Following Completion of Cardiac Rehabilitation Completed NCT00281424 Phase 2, Phase 3
10 Randomized Trial to Evaluate Mirasol Whole Blood Pathogen Reduction Technology System to Reduce Malaria and Emerging Transfusion Transmitted Infections Recruiting NCT03737669 Phase 3
11 A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRXâ„¢ Anorectal Wand Unknown status NCT03302858 Phase 2
12 Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular Malformation : An Open-label, Randomized, Parallel Controlled Study Completed NCT00964496 Phase 2 Thalidomide;Iron
13 Antagonists NMDA in Relay to Ketamine in Neuropathic Pain Completed NCT01602185 Phase 2 Dextromethorphan (drug used like antitussive);Memantine (drug used in Alzheimer's disease);Placebo (lactose)
14 Treatment of Oral Lichen Planus Lesions Completed NCT00746772 Phase 2 Purslane 235mg/day in one dosage;Placebo : one dosage
15 The Effects of Lactulose Supplementation to Enteral Feedings in Premature Infants - A Pilot Study Completed NCT00616876 Phase 2 Lactulose
16 Living With Hope: Developing a Psychosocial Supportive Program for Rural Older Women Caregivers of Spouses With Advanced Cancer Completed NCT01081301 Phase 2
17 Lenalidomide, Bortezomib, and Dexamethasone Combination Therapy as Induction Followed by Bortezomib and Lenalidomide Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma Recruiting NCT03641456 Phase 2 bortezomib;Lenalidomide;Dexamethasone
18 The Effectiveness of High and Low Intensity Intervention for Smoking Cessation During Pregnancy Completed NCT01210118 Phase 1
19 Hypertension Disorders During Pregnancy and Multi-exposure to Environmental Noise and Atmospheric Pollution in an Urban Setting: Case-control Study in Women Who Gave Birth at Dijon and Besançon CHUs Between 2005 and 2009 Unknown status NCT03261245
20 Clinical and Radiographic Evaluation of Papilla Preservation Flap With or Without Nanocrystalline Hydroxyapatite Bone Graft for Management of Periodontal Intrabony Defects: A Randomized Controlled Clinical Trial Unknown status NCT03588507
21 Effects of Continuous Veno-venous Haemofiltration on Plasma Lactate in Critically Ill Patients Unknown status NCT01824771
22 Effects of a Dietary Supplement on the Incidence of Acute Respiratory Infections in Susceptible Adults Completed NCT02210156
23 Acute D2 Receptor Blockade Induced Neuronal Network Changes in Human Volunteers Completed NCT01931059 Risperidone
24 Respiratory Symptoms, Asthma and Passive Smoking in Children: Effectiveness of an Integrated Individual, Family, and School-based Intervention Completed NCT01881607
25 A Comparison Between Two Educational Methods in the Rehabilitation of the Microstomia in Systemic Sclerosis: a Randomized Controlled Trial Completed NCT03766243
26 Computer-Delivered Motivational Intervention to Improve Teen Diabetes Management Completed NCT01515930
27 Fall Prevention by Assistant Nurses Among Community Living Elderly With Risk of Falling - a Randomized Controlled Trial Completed NCT01705912
28 Effectiveness Trial of Methods for Engaging Parents Into Parenting Interventions Completed NCT03147716
29 Evaluation of the Effectiveness of Endoscopic "Rendez-vous" Technique for Esophageal Reconstructions for the Treatment of a Total and Extensive Disruption of the Esophagus Completed NCT02166957
30 Surveillance of Obesity and Pre-Diabetes/Diabetes in Kiritimati School Children and Lifestyle Modifications to Reduce Risk Completed NCT04319003
31 Effects of a Group-based Exercise and Educational Program on Physical Performance and Disease Self-management in Rheumatoid Arthritis: a Randomized Controlled Study Completed NCT01307787
32 Maternal Attachment and Depression Anxiety Score Evaluation in COVID-19 Positive Pregnant Women Completed NCT04629638
33 Partner Assistance in Learning and Performing Skin Self-Examination Completed NCT01013844
34 Internet-delivered Cognitive Behavior Therapy for Adolescents With Functional Gastrointestinal Disorders: a Pilot Study Completed NCT02033161
35 The Long Term Outcome of Varus Derotational Osteotomy for Legg-Calvé-Perthes' Disease Completed NCT02676271
36 "Lose 2 Win" Contests: A Novel Method to Motivate Weight Loss Maintenance Among College Students Completed NCT02021383
37 A Comparative Study of Three Airway Clearance Techniques With Different Autonomy Degrees in Non Cystic Fibrosis Bronchiectasis: Randomized Cross-over Trial. Completed NCT01854788
38 Group B Streptococcal Carrier State Prevalence Among Arab Pregnant Women in Northern Israel District Completed NCT02528890
39 Acupuncture Compared To Sham With a Placebo-Needle in Radiotherapy-Induced Nausea - a Randomised Controlled Study Completed NCT00621660
40 Effect of Dietary Protein Restriction on Prognosis in Patients With Diabetic Nephropathy Completed NCT01521910
41 A Safe Environment for Every Kid (SEEK) I: Preventing Child Maltreatment - A Role for Pediatrics Completed NCT00507299
42 Pilot Study of Effects of Virtual Gait Training on Walking Stability in Older Adults Completed NCT01607736
43 Effect of the PainCoach App on Pain and Opiate Use in the First Two Weeks After Total Knee Replacement: Randomised Controlled Trial Completed NCT03961152
44 Skin Cancer Screening and Education Program at Beaches Completed NCT00894855
45 Adaptation and Validation of the Clinical Assessment Inventory (CIA) for Eating Disorders. Assessment of Its Relation With Other Clinical Measures Completed NCT02483117
46 Calcium and Vitamin D Intakes in Children Completed NCT01638494
47 THE EFFECT OF PERÄ°NEUM MASSAGE WÄ°TH OLÄ°VE OÄ°L Completed NCT04157777
48 A Mixed-methods Evaluation of Sit-stand Workstations in an Office Setting: a Randomised Controlled Trial Completed NCT02496507
49 Pain Management in Primary Care: A Randomized Controlled Trial of a Computerized Decision Support Tool Completed NCT04716621
50 MODERATE CONTINUOUS TRAINING VERSUS HIIT ON CARDIOMETABOLIC AND PSYCHOSOCIAL VARIABLES IN CANCER STADIUM II.CONTROLLED RANDOMIZED TRIAL Completed NCT03915288

Search NIH Clinical Center for Gastric Antral Vascular Ectasia

Cochrane evidence based reviews: gastric antral vascular ectasia

Sources

Genetic Tests for Gastric Antral Vascular Ectasia

About this section
Sources

Anatomical Context for Gastric Antral Vascular Ectasia

About this section

MalaCards organs/tissues related to Gastric Antral Vascular Ectasia:

40
Liver, Skin, Bone, Whole Blood, Colon, Myeloid, Bone Marrow
Sources

Publications for Gastric Antral Vascular Ectasia

About this section

Articles related to Gastric Antral Vascular Ectasia:

(show top 50) (show all 477)
# Title Authors PMID Year
1
Is Endoscopic Band Ligation a Superior Treatment Modality for Gastric Antral Vascular Ectasia Compared to Argon Plasma Coagulation? 61
33435659 2021
2
Endoscopic treatment of gastric antral vascular ectasia in real-life settings: Argon plasma coagulation or endoscopic band ligation? 61
33128340 2021
3
Gastric antral vascular ectasia diagnosed in a 22-year-old patient. 61
32345578 2020
4
Everolimus-induced gastric antral vascular ectasia in advanced renal cancer. 61
33163931 2020
5
Gastric antral vascular ectasia in children, rare presentation. 61
33257371 2020
6
Outcome of gastric antral vascular ectasia and related anemia after orthotopic liver transplantation. 61
33312430 2020
7
Endoscopic band ligation compared to thermal therapy for gastric antral vascular ectasia: A systematic review and meta-analysis. 61
33210983 2020
8
Gastric antral vascular ectasia in a patient with lupus undergoing hemodialysis: a case report. 61
33167896 2020
9
Gastric vascular abnormalities: diagnosis and management. 61
32925176 2020
10
Gastric antral vascular ectasia in systemic sclerosis: Association with anti-RNA polymerase III and negative anti-nuclear antibodies. 61
32906028 2020
11
Gastric Antral Vascular Ectasia and Vitamin D Deficiency: New Associated Disease and Proposed Pathogenetic Mechanisms. 61
33106980 2020
12
Outcome of Conservative Therapy in Coronavirus disease-2019 Patients Presenting With Gastrointestinal Bleeding. 61
33519132 2020
13
Gastric Hyperplastic Polyps after Argon Plasma Coagulation for Gastric Antral Vascular Ectasia in Patients with Liver Cirrhosis - A Case Suggesting the "Gastrin Link Theory". 61
33116013 2020
14
Endoscopic radiofrequency ablation for the treatment of severe gastric antral vascular ectasia in patients with cirrhosis. 61
32925507 2020
15
Gastric Antral Vascular Ectasia Causing Refractory Anemia in a Patient With Systemic Sclerosis. 61
31107696 2020
16
Gastric Antral Vascular Ectasia Refractory to Endoscopic Treatment. 61
31812265 2020
17
Thalidomide for refractory gastrointestinal bleeding from vascular malformations in patients with significant comorbidities. 61
32874976 2020
18
Successful banding of nodular gastric antral vascular ectasia in patients with refractory anemia. 61
32289332 2020
19
Shared changes in angiogenic factors across gastrointestinal vascular conditions: A pilot study. 61
32844042 2020
20
Portal Hypertension and Chronic Kidney Disease Significantly Increase the Risk of Early Unplanned Readmissions in GAVE- Related Admissions. 61
32530981 2020
21
The cost-effectiveness of radiofrequency ablation for treating patients with gastric antral vascular ectasia refractory to first line endoscopic therapy. 61
32212980 2020
22
Magnifying endoscopy with narrow-band image for diagnosing diffuse type of gastric antral vascular ectasia in cirrhotic patients. 61
32433425 2020
23
Intravenous Bevacizumab Reduces Transfusion Requirements and Endoscopic Interventions in Patients With Gastric Antral Vascular Ectasia and Small Bowel Angioectasia. 61
31759060 2020
24
Diagnosis and Management of Gastric Antral Vascular Ectasia: Experience in a Large Single Cohort of Patients With Systemic Sclerosis. 61
32073520 2020
25
Gastric antral vascular ectasia (GAVE) and hereditary hemorrhagic telangiectasia (HHT): two different conditions, one treatment. 61
31773212 2020
26
The Use of Thalidomide in Severe Refractory Anaemia Due to Gastric Antral Vascular Ectasia (GAVE) in Cirrhosis? 61
33457370 2020
27
Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study. 61
32266280 2020
28
Long-term follow-up in patients with gastric antral vascular ectasia (GAVE) after treatment with endoscopic band ligation (EBL). 61
31788543 2019
29
'Watermelon stomach' as a presenting manifestation of systemic sclerosis. 61
31323093 2019
30
Severe gastrointestinal hemorrhage related to everolimus: a case report. 61
30955165 2019
31
Is endoscopic band ligation the gold standard for gastric antral vascular ectasia? 61
31790084 2019
32
Comparative Effectiveness and Safety of Radiofrequency Ablation Versus Argon Plasma Coagulation for Treatment of Gastric Antral Vascular Ectasia: A Systematic Review and Meta-Analysis. 61
29952856 2019
33
Safety and Tolerability of Thrombin Inhibition in Scleroderma-Associated Interstitial Lung Disease. 61
31777820 2019
34
Gastric antral vascular ectasia in portal hypertensive children: Endoscopic band ligation versus argon plasma coagulation. 61
30119927 2019
35
Response of authors to the comment on 'mucosal miR-3677 is over-expressed in cirrhotic patients with gastric antral vascular ectasia'. 61
31165646 2019
36
Killer-cell immunoglobulin-like receptor ligand mismatch cord blood transplantation in high-risk neuroblastoma. 61
30974480 2019
37
Comment on "Mucosal miR-3677 is over-expressed in cirrhotic patients with gastric antral vascular ectasia (GAVE)". 61
31095437 2019
38
Laparoscopic subtotal gastrectomy with Roux-en-Y reconstruction for long-term anticoagulation in gastric antral vascular ectasia syndrome. 61
31138599 2019
39
Radiofrequency ablation for patients with refractory symptomatic anaemia secondary to gastric antral vascular ectasia. 61
31080606 2019
40
Predictors of blood transfusion and in-hospital outcomes in patients with gastric antral vascular ectasia (GAVE): a nationwide population-based analysis. 61
30906750 2019
41
Intravenous Cyclophosphamide for Gastric Antral Vascular Ectasia Associated with Systemic Sclerosis Refractory to Endoscopic Treatment: A Case Report and Review of the Pertinent Literature. 61
30101944 2019
42
Histologic and Endoscopic Similarity between Nodular Gastric Antral Vascular Ectasia and Gastric Hyperplastic Polyps Potentially Causing Treatment Delays. 61
31662762 2019
43
[A case of gastric antral vascular ectasia improved by splenorenal shunt embolization]. 61
31597880 2019
44
Mucosal miR-3677 is over-expressed in cirrhotic patients with gastric antral vascular ectasia (GAVE). 61
30621516 2018
45
Features of multiple self-healing squamous epithelioma and Loeys-Dietz syndrome in a patient with a novel TGFBR1 variant. 61
30513140 2018
46
Diagnosis and Management of Gastric Antral Vascular Ectasia: Experience in a Large Single Cohort of Patients With Systemic Sclerosis. 61
30431488 2018
47
Angiosarcoma with Synchronous Cutaneous and Small Bowel Involvement: A Report of a Rare Presentation. 61
30723649 2018
48
Nitrous oxide cryotherapy ablation for refractory gastric antral vascular ectasia. 61
30288277 2018
49
Gastric Antral Vascular Ectasia Pathogenesis and the Link to the Metabolic Syndrome. 61
29961911 2018
50
New Indications for Endoscopic Radiofrequency Ablation. 61
29081376 2018
Sources

Variations for Gastric Antral Vascular Ectasia

About this section
Sources

Expression for Gastric Antral Vascular Ectasia

About this section
Search GEO for disease gene expression data for Gastric Antral Vascular Ectasia.
Sources

Pathways for Gastric Antral Vascular Ectasia

About this section

Pathways related to Gastric Antral Vascular Ectasia according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Salivary secretion 36
Show member pathways
 11.56 SST GAST ATP4A
2
Secretion of Hydrochloric Acid in Parietal Cells 1
9.32 GAST ATP4A
Sources

GO Terms for Gastric Antral Vascular Ectasia

About this section

Biological processes related to Gastric Antral Vascular Ectasia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 response to drug GO:0042493 9.54 TOP1 SST OXCT1
2 potassium ion import across plasma membrane GO:1990573 9.32 ATP4A ATP12A
3 cellular sodium ion homeostasis GO:0006883 9.26 ATP4A ATP12A
4 sodium ion export across plasma membrane GO:0036376 9.16 ATP4A ATP12A
5 cellular potassium ion homeostasis GO:0030007 8.96 ATP4A ATP12A
6 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 8.62 ATP4A ATP12A

Molecular functions related to Gastric Antral Vascular Ectasia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sodium:potassium-exchanging ATPase activity GO:0005391 9.16 ATP4A ATP12A
2 potassium-transporting ATPase activity GO:0008556 8.96 ATP4A ATP12A
3 potassium:proton exchanging ATPase activity GO:0008900 8.62 ATP4A ATP12A
Sources

Sources for Gastric Antral Vascular Ectasia

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Mar-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....